trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

PCSK9 has biological functions other than LDL cholesterol control

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that PCSK9 has biological functions other than LDL cholesterol control?

Yes. Multiple studies demonstrate that PCSK9 has pleiotropic, biological functions beyond regulating LDL cholesterol, including roles in inflammation, hemostasis, platelet activation, and neuronal protection.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently support the claim that PCSK9 has biological functions outside of LDL cholesterol control. Multiple reviews and experimental studies document its involvement in thrombosis, platelet reactivity, neuroinflammation, immune responses, and vascular inflammation. There are no refuting studies in the provided set.

Evidence for · 7
2019
Pretreatment with a PCSK9 inhibitor reduces neuronal inflammation and amyloid-beta aggregation in the brain following cardiac ischemia/reperfusion injury.
Get citation
Apaijai, N., Moisescu, D. M., Palee, S., McSweeney, C. M., Saiyasit, N., Maneechote, C., Boonnag, C., Chattipakorn, N., & Chattipakorn, S. (2019). Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation. doi.org. https://doi.org/10.1161/JAHA.118.010838

See more details
More for · 6
2019
PCSK9 influences hemostasis and thrombosis by modulating platelet activation and blood coagulation independently of LDL cholesterol.
Get citation
Paciullo, F., Momi, S., & Gresele, P. (2019). PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention. doi.org. https://doi.org/10.1055/s-0038-1676863

2020
PCSK9 is described as a ubiquitous protein involved in immune response, hemostasis, glucose metabolism, and neuronal survival.
Get citation
Cesaro, A., Bianconi, V., Gragnano, F., Moscarella, E., Fimiani, F., Monda, E., Scudiero, O., Limongelli, G., Pirro, M., & Calabrò, P. (2020). Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition. doi.org. https://doi.org/10.1002/biof.1619

2022
PCSK9 knockout animals exhibit reduced platelet activity and arterial thrombosis, indicating lipid-independent roles in thrombogenesis.
Get citation
Puccini, M., Landmesser, U., & Rauch, U. (2022). Pleiotropic Effects of PCSK9: Focus on Thrombosis and Haemostasis. doi.org. https://doi.org/10.3390/metabo12030226

2022
PCSK9 inhibitors modulate extrahepatic lipid metabolism by increasing cholesterol efflux and altering serum cholesterol loading capacity.
Get citation
Palumbo, M., Giammanco, A., Purrello, F., Pavanello, C., Mombelli, G., Pino, A. D., Piro, S., Cefalù, A., Calabresi, L., Averna, M., Bernini, F., Zimetti, F., Adorni, M., & Scicali, R. (2022). Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation. doi.org. https://doi.org/10.3389/fmolb.2022.925587

2022
PCSK9 monoclonal antibodies exhibit non-lipid effects, such as reducing platelet aggregation, decreasing venous thromboembolism, and improving endothelial function.
Get citation
Ugovšek, S. & Šebeštjen, M. (2022). Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall. doi.org. https://doi.org/10.3390/jcm11133625

2025
PCSK9 interacts with receptors like CD36, LRP-1, and ABCA1 in the vascular system, supporting LDLR-independent signaling pathways.
Get citation
Liu, G., Yu, X., Cui, C., Li, X., Wang, T., Palade, P., Mehta, J. L., & Wang, X. (2025). The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism. doi.org. https://doi.org/10.1111/apha.14272

Related receipts

What does the evidence say?

The retrieved papers consistently support the claim that PCSK9 has biological functions outside of LDL cholesterol control. Multiple reviews and experimental studies document its involvement in thrombosis, platelet reactivity, neuroinflammation, immune responses, and vascular inflammation. There are no refuting studies in the provided set.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8704 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work